Elsa Mondou

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

Patrick Marcellin, E. Jenny Heathcote, Ed Gane et al. · New England Journal of Medicine · 2008 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

E. Jenny Heathcote, Patrick Marcellin, Edward Gane et al. · Gastroenterology · 2010 · 461 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Yun‐Fan Liaw, I‐Shyan Sheen, Chuan–Mo Lee et al. · Hepatology · 2010 · 323 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

John O. Link, James G. Taylor, Lianhong Xu et al. · Journal of Medicinal Chemistry · 2013 · 292 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of GS-9450 in Subjects With Nonalcoholic Steatohepatitis

Vlad Ratziu, Muhammad Y. Sheikh, Arun J. Sanyal et al. · Hepatology · 2011 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17